India restricts use of Chlorpheniramine Maleate and Phenylephrine Hydrochloride FDC in children…
Manufacturers required to display warning on labels, inserts and promotional material following safety concerns
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark to launch generic version of Adderall Tablets in the US market by May 2025
Company announces bioequivalent and therapeutically equivalent version of Mixed Salts of a Single Entity Amphetamine Product…
Pharma experts spotlight GenAI’s transformative role in life sciences
Leaders from GSK, L’Oréal Lifesciences, Sravathi AI, and GAVS discussed how generative AI is being applied for drug discovery,…
Shilpa Medicare receives CDSCO SEC Nod for IND Nor UDCA tablets for NAFLD treatment
Shilpa Medicare secures Subject Expert Committee approval for its novel therapy Nor Ursodeoxycholic Acid, following positive phase…
Sun Pharma appoints Shaik Barak Tulla as Senior Vice President
Shaik Barak Tulla to drive commercial planning and business acceleration at Sun Pharma with over 25 years of pharma industry…
Parexel appoints Dr Charlotte Moser as Chief Medical Officer to lead global clinical development…
Dr Moser brings over 25 years of clinical and regulatory experience to Parexel’s global drug development and trial delivery…
COPD market to surpass $30.2 billion in 7MM in 2033, driven by biologics and precision medicine,…
Precision medicine and biologics drive a paradigm shift in COPD treatment across the US, EU5, and Japan, but pricing pressures and…
Meribel Pharma Solutions launches as mid-sized European CDMO with multi-country network
Following acquisitions across France, Spain and Sweden, Meribel Pharma Solutions enters the CDMO market with ten manufacturing…
Tamil Nadu seize unlicensed hair oils allegedly containing rabbit blood following NGO complaint
Acting on a formal complaint from Humane World for Animals India, the Tamil Nadu Drugs Control Department has seized unauthorised…
OX40 inhibitors may transform atopic dermatitis landscape: GlobalData
GlobalData highlights how OX40 inhibitors, led by rocatinlimab, could reshape moderate-to-severe atopic dermatitis treatment by…